News GSK COPD combination better than AZ rival - trial GSK plans to file triple combination therapy by end of the year.
News AZ sells US, EU and Latin America rights to gout drug AZ focused on sales target set by CEO Pascal Soriot.
News AstraZeneca unveils genomics collaboration to aid drug disco... AstraZeneca has launched a new 'integrated genomics approach' to expand the genetic basis of its research, and aid drug discovery and development.
Articles AstraZeneca, Genentech fund PatientsLikeMe research into can... PatientsLikeMe is working with AstraZeneca and Roche to find about more about the experiences of people being treated for lung cancer
News Lilly pays AstraZeneca $100m as Alzheimer's drug enters phas... AstraZeneca and Eli Lilly are to continue with a pivotal phase 2/3 study of a key pipeline drug, AZD3293 for early Alzheimer's disease, after interim safety data boosted confidence in the d
News MSD takes a $400m bite of SciBrunch's KRAS drug MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
